rejoy-heath-logo
    • RejoyGPT
    • AI Scribe
    • AI Coder
    • AI Receptionist
    • AI Interpreter
    • Clinical Decision Support
    • Medical Search
  • Features
  • Pricing
Request a Demo

Products

  • RejoyGPT
  • AI Scribe
  • AI Coder
  • AI Receptionist
  • AI Interpreter
  • Clinical Decision Support
  • Medical Search
  • Features
  • Pricing
Request a Demo
rejoy-heath-logo
    • RejoyGPT
    • AI Scribe
    • AI Coder
    • AI Receptionist
    • AI Interpreter
    • Clinical Decision Support
    • Medical Search
  • Features
  • Pricing
Request a Demo

Products

  • RejoyGPT
  • AI Scribe
  • AI Coder
  • AI Receptionist
  • AI Interpreter
  • Clinical Decision Support
  • Medical Search
  • Features
  • Pricing
Request a Demo
rejoy-heath-logo
Company

The AI care team for clinics and hospitals. Scribe, coder, reception, interpretation, and clinical answers in one suite. You stay in charge.

Contact
Click here to
Contact Support
on WhatsApp

600 California St,

San Francisco, CA 94108

hello@rejoyhealth.com
AI care team
RejoyGPTAI ScribeAI CoderAI ReceptionistAI InterpreterClinical Decision SupportMedical Search
Resources
ResourcesQuestion BankContestsCommunityBlogSearch SymptomsSearch CalculatorsSearch DrugsSymptom CheckerPricing
Terms and conditions
Privacy policyTerms of Service
Published on November 18, 2026

Metoprolol Recall 2026: 3,684 Bottles of Blood Pressure Medication Recalled Over Foreign Tablets

Now Hiring · Rejoy Health Team

We're hiring AI Trainers. Remote, contract, $75 to $100 +/hr.

Help train and evaluate the models behind Rejoy Health. No medical or technical background needed. If you write clearly in English, Spanish, French, or another language, we want to hear from you. Work remotely, on your own schedule.

View the role

A nationwide metoprolol recall affects 3,684 bottles of 50 mg blood pressure medication after possible contamination with unidentified tablets or capsules. Learn which batches are affected and what patients should know.

Nationwide Recall Issued for Metoprolol Blood Pressure Medication

Thousands of bottles of a prescription medication used to manage high blood pressure and certain heart conditions are being recalled nationwide after concerns that some containers may contain unidentified tablets or capsules.

The voluntary recall was initiated by Advagen Pharma Limited, a pharmaceutical company based in East Windsor, New Jersey. According to a U.S. Food and Drug Administration (FDA) enforcement report, the recall affects 3,684 bottles of metoprolol tartrate 50 mg tablets distributed across the United States.

The company initiated the recall on October 27, 2026, and initially notified recipients through written letters. The FDA subsequently classified the action as a Class II recall on November 10, 2026.

The recall has raised concerns about medication safety, particularly among patients who depend on metoprolol to control blood pressure, manage chest pain, and treat other cardiovascular conditions.

Why Is Advagen Pharma Recalling Metoprolol?

The FDA identified the reason for the recall as the presence of foreign tablets or capsules inside the affected medication bottles.

This means that containers intended to hold metoprolol tablets may contain other unidentified medication products.

However, the FDA enforcement report did not specify which tablets or capsules were discovered, how many foreign pills may be present, or how they entered the affected bottles.

The agency also did not provide information about the identity, dosage, or potential effects of the unidentified medication.

The absence of these details means that patients and healthcare professionals cannot determine from the recall announcement alone whether the additional tablets could cause drug interactions or other health problems.

For this reason, people who have prescriptions for metoprolol should carefully check their medication packaging and contact their pharmacist or healthcare provider if they have concerns.

Which Metoprolol Bottles Are Included in the Recall?

The recall specifically involves metoprolol tartrate 50 mg tablets manufactured and distributed by Advagen Pharma Limited.

The affected products were supplied in large bottles containing 1,000 tablets each.

Patients, pharmacists, and healthcare providers can use the following product information to determine whether their medication may be included in the recall.

Metoprolol Recall Product Details:

  • Manufacturer: Advagen Pharma Limited
  • Product: Metoprolol Tartrate Tablets
  • Strength: 50 mg
  • Package Size: 1,000 tablets per bottle
  • Affected Quantity: 3,684 bottles
  • Lot Number: 2611C065A1
  • Expiration Date: May 2028
  • National Drug Code (NDC): 72888-210-00
  • Recall Initiation Date: October 27, 2026
  • FDA Classification Date: November 10, 2026
  • Recall Classification: Class II

The National Drug Code, or NDC, is a product identification number used to identify drug products and their packaging.

Patients should compare the lot number and NDC printed on their medication packaging with the information listed above. Anyone who is uncertain about whether their prescription is affected should ask a pharmacist to check the product.

What Does an FDA Class II Drug Recall Mean?

The FDA classifies product recalls according to the potential health risks associated with the affected products.

In this case, metoprolol was assigned a Class II recall classification.

According to the FDA, a Class II recall involves a situation in which exposure to or use of a recalled product may result in temporary or medically reversible health consequences. The likelihood of serious adverse health effects is considered remote.

This classification does not mean that every affected bottle will necessarily cause a health problem. However, it indicates that the product may present a potential safety concern and that appropriate action should be taken.

The FDA report did not identify any confirmed patient injuries or adverse reactions associated with this particular recall.

It also did not specify which pharmacies received the affected bottles or provide individual instructions for patients who may have purchased the medication.

Should Patients Stop Taking Metoprolol?

One of the most important concerns for patients is whether they should immediately stop taking their blood pressure medication.

According to FDA guidance, consumers can generally continue using medications involved in Class II or Class III recalls unless the recalling company provides different instructions.

However, patients should not make changes to their prescribed medication without consulting a healthcare professional.

MedlinePlus warns that abruptly stopping metoprolol can lead to serious heart-related complications. Suddenly discontinuing the medication may increase the risk of chest pain and other cardiovascular problems.

Patients who suspect they have an affected bottle should contact their pharmacist or prescribing doctor for specific instructions.

Healthcare professionals can help determine whether the medication needs to be replaced and explain how to maintain treatment safely.

Patients should never take unidentified tablets or capsules found inside their prescription bottles.

What Is Metoprolol Used For?

Metoprolol belongs to a class of medications known as beta blockers. These drugs work by affecting certain responses of the heart and circulatory system.

The medication slows the heart rate and reduces the workload on the heart. It also helps lower blood pressure, making it useful for treating several cardiovascular conditions.

Doctors commonly prescribe metoprolol for:

  • High blood pressure: Helps lower blood pressure and reduce the risk of complications associated with hypertension.
  • Chest pain: Helps manage angina by reducing the heart's workload.
  • Heart failure: Certain formulations are prescribed to help manage specific types of heart failure.
  • Heart attack recovery: May be used to improve survival and reduce the risk of further cardiovascular complications after a heart attack.

Although metoprolol helps control these conditions, it does not cure them. Patients generally need to follow their prescribed treatment plans and attend regular medical appointments.

Common Metoprolol Side Effects to Know

Like other prescription medications, metoprolol can cause side effects.

Some patients experience mild symptoms as their bodies adjust to treatment. Reported side effects include:

  • Dizziness or lightheadedness
  • Unusual tiredness
  • Diarrhea
  • Dry mouth
  • Skin rash
  • Itching

More serious symptoms require immediate medical attention. These may include difficulty breathing, fainting, swelling, or a rapid, pounding, or irregular heartbeat.

Patients should contact a healthcare professional if they experience unusual symptoms or suspect that they may have taken an unidentified medication.

It is also important to follow the prescribed dosage. Patients should not increase, decrease, or change how frequently they take metoprolol without medical advice.

If a dose is missed, MedlinePlus advises patients to skip the missed dose and return to their regular schedule rather than taking an additional dose to compensate.

How Can Patients Report Problems With Recalled Medication?

Patients and healthcare professionals who experience or identify potential problems involving prescription medications can report them through the FDA's MedWatch program.

MedWatch is the FDA's safety reporting system for adverse events and problems involving prescription drugs, medical devices, and other regulated health products.

The program accepts reports from consumers, patients, and healthcare professionals.

Reporting suspected medication-related problems helps the FDA collect safety information and identify potential risks associated with regulated products.

Patients should also notify their pharmacist and prescribing healthcare provider if they discover unidentified tablets or capsules in a prescription bottle.

What Patients Should Remember About the 2026 Metoprolol Recall

The Advagen Pharma recall affects 3,684 bottles of metoprolol tartrate 50 mg tablets distributed nationwide. The FDA identified the presence of foreign tablets or capsules as the reason for the recall and classified the action as Class II.

Although the FDA has not reported confirmed injuries connected to this recall, patients should take the announcement seriously.

Checking the medication's lot number, NDC, and expiration date is an important first step. Anyone who identifies a potentially affected bottle should contact their pharmacist or healthcare provider for guidance.

Most importantly, patients should not abruptly discontinue metoprolol without medical advice, as doing so may lead to serious cardiovascular complications.

Staying informed about medication recalls and following professional medical guidance can help patients make safer decisions about their treatment.

Sources:

  1. U.S. Food and Drug Administration (FDA), Drug Recalls and Enforcement Reports, Advagen Pharma Limited Metoprolol Tartrate Recall, November 2026.
  2. U.S. Food and Drug Administration (FDA), Recall Classification Definitions and Consumer Guidance.
  3. MedlinePlus, Metoprolol Drug Information, U.S. National Library of Medicine.
  4. U.S. Food and Drug Administration (FDA), MedWatch: The FDA Safety Information and Adverse Event Reporting Program.

Medical Disclaimer: This article is intended for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Patients should consult their doctors or pharmacists about recalled medications and should never stop taking prescribed medication without appropriate medical guidance.

Now Hiring · Rejoy Health Team

Speak English, Spanish, or French? Get paid to train AI.

Rejoy Health is looking for AI Trainers to review model responses, write reference answers, and flag replies that are confusing or unhelpful. You will shape how millions of people receive health information, one careful judgement at a time. There is no degree, medical background, or coding experience required. If you can read and write well in English, Spanish, French, or another language, you can do this work. Remote and contract, $75 to $100+/hr, with hours that fit around study, work, or family commitments.

Apply today

Share this post

Explore Related Articles for Deeper Insights

New World Screwworm Detected in Arizona Dog as US Cases Expand
New World screwworm has been confirmed in a dog in Arizona, raising concerns about animal health, li...
View article →
US FDA Orders Eye Safety Warnings for Weight-Loss Drugs as 28 Million Americans Use GLP-1 Medications
The FDA is requiring weight-loss drug manufacturers to add warnings about a rare eye condition that ...
View article →
New Research Raises Fresh Concerns About the Long-Term Impact of Vaping on Lung Health
For years, vaping has been marketed and perceived by many as a safer alternative to traditional smok...
View article →

To get more personalized answers,
download now

Login
Register